Sanctuary Advisors LLC Makes New $415,000 Investment in Hims & Hers Health, Inc. (NYSE:HIMS)

Sanctuary Advisors LLC bought a new position in shares of Hims & Hers Health, Inc. (NYSE:HIMS) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 20,552 shares of the company’s stock, valued at approximately $415,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Arizona State Retirement System lifted its position in Hims & Hers Health by 3.0% during the 2nd quarter. Arizona State Retirement System now owns 40,344 shares of the company’s stock worth $815,000 after acquiring an additional 1,173 shares during the last quarter. Victory Capital Management Inc. raised its position in shares of Hims & Hers Health by 6.6% during the second quarter. Victory Capital Management Inc. now owns 19,469 shares of the company’s stock valued at $393,000 after buying an additional 1,212 shares during the last quarter. Nisa Investment Advisors LLC raised its position in shares of Hims & Hers Health by 679.2% during the second quarter. Nisa Investment Advisors LLC now owns 1,839 shares of the company’s stock valued at $37,000 after buying an additional 1,603 shares during the last quarter. Swiss National Bank raised its position in shares of Hims & Hers Health by 0.7% during the first quarter. Swiss National Bank now owns 281,500 shares of the company’s stock valued at $4,355,000 after buying an additional 2,000 shares during the last quarter. Finally, ProShare Advisors LLC raised its position in shares of Hims & Hers Health by 10.0% during the first quarter. ProShare Advisors LLC now owns 22,257 shares of the company’s stock valued at $344,000 after buying an additional 2,023 shares during the last quarter. Institutional investors and hedge funds own 63.52% of the company’s stock.

Insider Activity at Hims & Hers Health

In related news, CEO Andrew Dudum sold 188,888 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $16.47, for a total value of $3,110,985.36. Following the completion of the sale, the chief executive officer now owns 33,502 shares of the company’s stock, valued at $551,777.94. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, CEO Andrew Dudum sold 188,888 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $16.47, for a total value of $3,110,985.36. Following the completion of the sale, the chief executive officer now owns 33,502 shares of the company’s stock, valued at $551,777.94. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Oluyemi Okupe sold 269,739 shares of the firm’s stock in a transaction that occurred on Monday, October 14th. The shares were sold at an average price of $20.31, for a total transaction of $5,478,399.09. Following the completion of the sale, the chief financial officer now directly owns 145,763 shares of the company’s stock, valued at approximately $2,960,446.53. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 835,911 shares of company stock valued at $14,640,096 over the last quarter. Corporate insiders own 17.71% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Needham & Company LLC assumed coverage on shares of Hims & Hers Health in a research report on Thursday, August 22nd. They set a “buy” rating and a $24.00 price objective for the company. Truist Financial upped their price objective on shares of Hims & Hers Health from $13.00 to $23.00 and gave the company a “hold” rating in a research report on Thursday, July 18th. Imperial Capital lowered shares of Hims & Hers Health from an “outperform” rating to an “in-line” rating in a research report on Friday, August 9th. Jefferies Financial Group upped their price objective on shares of Hims & Hers Health from $14.00 to $23.00 and gave the company a “hold” rating in a research report on Thursday, June 27th. Finally, Piper Sandler reaffirmed a “neutral” rating and set a $18.00 price objective on shares of Hims & Hers Health in a research report on Tuesday, August 6th. Eight analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $20.07.

Hims & Hers Health Trading Down 1.9 %

NYSE HIMS opened at $22.36 on Thursday. The firm has a market cap of $4.80 billion, a price-to-earnings ratio of -2,236.00 and a beta of 1.06. The company has a 50 day moving average of $16.70 and a 200-day moving average of $17.50. Hims & Hers Health, Inc. has a 1-year low of $5.65 and a 1-year high of $25.74.

Hims & Hers Health (NYSE:HIMS) last posted its quarterly earnings data on Monday, August 5th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.02. The company had revenue of $315.65 million during the quarter, compared to analyst estimates of $302.43 million. Hims & Hers Health had a net margin of 1.70% and a return on equity of 5.25%. The company’s revenue was up 51.8% on a year-over-year basis. During the same quarter last year, the business posted ($0.03) earnings per share. On average, analysts forecast that Hims & Hers Health, Inc. will post 0.22 earnings per share for the current year.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.